C34H39N3O8 Cytidine, 5'-o- BIS (4-athoxyphenyl) phenylmethyl] -2''-o-

SMILSICAL CLAMES O = C1N = C (N) C (CN1C2OC (CC = CC = CC = CC = CC = CC = c5) C = c5) c
Ko nga ataata Isomeric C (OC [C3 H] (C3 = c3) c = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = cc = CC = c
Hapani
Inchi = 1s / C34H39N3O8 / C1-22-27 / 33 (39) 36-31 (43-19 (43-19-18-27 (43-39) 21-44-34 (454-10-10-10-10-14-10-14-10-14-10-14-10-14-10-14 1-3) 15-11-24) 25-11-26-27 (42-25 / H5-117,20,38H0,38H0,38H3,38H3,38,38,31H2,13,36,36,39) / T18-, 32-, 32- / M1 / ​​S1
Inchi Key
Lyktvjjxzqtnpk-Pbamlimusa-n
24 etahi atu ingoa mo tenei taonga
5'- O- [BIS (4-athoxyphenyl) phenylmethyl] -2''-o- 11: PN: US20030170636 Whārangi: 17 I kii a RNA; 12: PN: US200302111606 Whārangi: 18 I kii a NA; 12: PN: US2003021717 Whārangi: 19 I kii a R N; 14: PN: US20040005569 PAG E: 21 I kii r N; 15: PN: US20040005565 Whārangi: 17- 22 I kii a RNA; 15: PN: US20040005570 Whārangi: 19 I kii a R N; 15: PN: U S20040006030 Whārangi: 22 kereme r na; 15: PN: US20040014048 Whārangi: 19 kereme r na; 16: PN: US2003017133 Whārangi: 9 i kii a RNA; 16: PN: US200301995 Whārangi: 19 I kii a R N; 16: PN: US2004001474 Whārangi: 19 I kii a n; 16: PN: US2004001499 Whārangi:

19 Ka kii a RNA; 17: PN: US20040014051 Whārangi: 21 kereme r na; 17: PN: US20040014699 Whārangi: 19 I kii a R N; 17: PN: W
O03106645 Whārangi: 69 I kii a R N; 18: PN: US20040006029 Whārangi: 22 kereme r na; 2'-o-methoxyethyl-5'-o-dimethoxytrityl-5-thylcytidine; 58: PN: US20030166592 Whārangi: 15 I kii r NO; 5: PN: WO200500658 Whārangi: 61 kereme r na; 7: PN: WO20050 07825 Whārangi: 61 I kii a n; 82: PN: US200401717176 Whārangi: 18 I kii a R N; 89: PN: US20040005707 Whārangi: 19 I kii a N NO; 9: PN: WO03084478 Whārangi: 56 I kii a R N